Radium-223 Alpha Emitter Agent in Non-intervention Safety Study in mCRPC popUlation for Long-teRm Evaluation
Radium-223 Alpha Emitter Agent in Non-intervention Safety Study in mCRPC popUlation for Long-teRm Evaluation
Observational study in the routine clinical practice setting to evaluate the short and long term safety profile of Radium-223 in metastatic castration resistant prostate cancer patients and to evaluate the risk of developing second primary cancers.
Inclusion Criteria:
Exclusion Criteria:
Township, New Jersey, United States
Multiple Locations, Argentina
Multiple Locations, Austria
Multiple Locations, Belgium
Multiple Locations, Canada
Multiple Locations, Colombia
Multiple Locations, Czechia
Multiple Locations, Denmark
Multiple Locations, France
Multiple Locations, Germany
Multiple Locations, Greece
Multiple Locations, Israel
Multiple Locations, Italy
Multiple Locations, Luxembourg
Multiple Locations, Mexico
Multiple Locations, Netherlands
Multiple Locations, Portugal
Multiple Locations, Spain
Multiple Locations, Sweden
Multiple Locations, United Kingdom